浔兴股份(002098) - 2022 Q3 - 季度财报

Financial Performance - Revenue for Q3 2022 was CNY 525,992,340.43, a decrease of 13.60% compared to the same period last year[5]. - Net profit attributable to shareholders was CNY 11,447,510.44, down 76.30% year-on-year[5]. - Net profit after deducting non-recurring gains and losses was CNY 13,175,542.58, a decrease of 71.79% compared to the previous year[5]. - The net profit for Q3 2022 was CNY 57,264,326.06, a decrease of 55.3% compared to CNY 128,011,334.36 in Q3 2021[34]. - The operating profit for Q3 2022 was CNY 62,996,818.08, down 55.8% from CNY 142,214,935.45 in the same period last year[34]. - The total comprehensive income for Q3 2022 was CNY 57,407,587.00, compared to CNY 127,957,702.43 in Q3 2021[35]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,869,211,554.09, a decrease of 14.35% from the end of the previous year[5]. - Total assets decreased to CNY 1,869,211,554.09 from CNY 2,114,363,257.58, a reduction of about 11.6%[31]. - Total liabilities decreased to CNY 782,126,788.30 from CNY 1,084,773,458.79, indicating a decline of approximately 27.8%[30]. - The company's total equity increased to CNY 1,087,084,765.79 from CNY 1,029,589,798.79, reflecting a growth of about 5.6%[31]. Cash Flow - The net cash flow from operating activities for the year-to-date was CNY 202,935,153.27, an increase of 1,237.05%[5]. - The net cash flow from operating activities for Q3 2022 was CNY 202,935,153.27, significantly up from CNY 15,177,875.70 in Q3 2021[38]. - The company reported a net cash outflow from investing activities of CNY 60,760,146.40, compared to a net inflow of CNY 95,441,969.72 in the previous year[38]. - Cash and cash equivalents decreased to CNY 218,379,311.70 from CNY 293,601,120.92, reflecting a decline of approximately 25.6%[27]. - The cash and cash equivalents at the end of Q3 2022 amounted to CNY 204,432,392.58, an increase from CNY 159,099,753.74 at the end of Q3 2021[39]. Shareholder Information - Total number of ordinary shareholders at the end of the reporting period was 17,758[14]. - The largest shareholder, Tianjin Huizefeng Enterprise Management Co., Ltd., holds 25% of the shares, all of which are pledged and frozen due to debt disputes[18]. - Shareholder Fujian Xunxing Group Co., Ltd. increased its holdings by 1,885,400 shares, approximately 0.53% of the total share capital[19]. Governance and Compliance - The company is under investigation by the China Securities Regulatory Commission for suspected violations of information disclosure laws[21]. - The company appointed a new financial director on September 23, 2022, following the resignation of the previous director[24]. - The company revised several governance documents to enhance corporate governance and protect minority investors' rights[25]. Operational Metrics - Total operating revenue for the period reached CNY 1,617,455,230.18, an increase from CNY 1,581,883,506.39 in the previous period, representing a growth of approximately 2.3%[32]. - Total operating costs amounted to CNY 1,536,078,965.53, up from CNY 1,444,782,688.52, indicating an increase of about 6.5%[32]. - Cash received from investment decreased by 41.97% to ¥305,900,000 compared to the same period last year due to a reduction in idle fund management amounts[12]. - Cash received from investment income fell by 36.25% to ¥566,973.81, reflecting a decrease in idle fund management income[12]. - Cash from the disposal of fixed assets decreased by 77.05% to ¥110,130.00, indicating a significant drop in cash recovered from asset disposals[12]. - Cash paid for investments decreased by 36.90% to ¥315,000,000, attributed to a reduction in idle fund management amounts[12]. - Cash paid for debt repayment decreased by 51.74% to ¥254,000,000, as part of a strategy to reduce loan scale[12]. Income and Expenses - Financial expenses decreased by 74.91% to CNY 7,243,967.23 due to a reduction in average interest-bearing liabilities[11]. - The company incurred financial expenses of CNY 7,243,967.23, a decrease of 74.9% from CNY 28,875,253.33 in the previous year[34]. - The company reported an asset impairment loss of CNY 9,302,156.01, attributed to increased inventory write-downs[11]. - The company reported a decrease in sales expenses to CNY 287,913,332.42 from CNY 254,768,791.07, reflecting a 13% increase year-over-year[34]. - Investment income decreased by 40.87% to CNY 540,130.41 due to a reduction in idle fund management amounts[11]. Inventory and Receivables - Accounts receivable decreased to CNY 357,519,986.73 from CNY 401,395,738.66, a reduction of about 10.9%[28]. - Inventory decreased to CNY 293,532,023.44 from CNY 410,767,150.29, showing a decline of approximately 28.5%[28]. Patents and Innovations - The company added 39 new authorized patents in the first nine months of 2022, including 10 invention patents[17].